HIV Antiretroviral Therapy (ART) Adherence
14
8
8
1
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 25/100
0.0%
0 terminated out of 14 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
100%
1 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (14)
Developing and Testing a Digital Health Tool for INterseCtional Stigma Assessment and Reduction at Multiple Levels and mUltiple DimEnsions (INCLUDE) to Improve HIV Care in ART Centers in Nepal
Prevention of Mother-to-child Transmission (PMTCT) Among Women Experiencing Depression in Malawi
Transitional Housing and HIV Health
Cash Transfers to Pregnant Women With HIV
Hybrid Type-1 Effectiveness-Implementation Trial of Motivation Matters!
Implementation and Effects of Nishauri on HIV Treatment Outcomes Among Men
Optimizing Prevention and Care for Pregnant and Postpartum Adolescent Girls and Young Women With HIV in Tanzania
Pilot of an Intervention to Reduce Alcohol Use and Improve ART Adherence Among Men Living With HIV With Pregnant Partners in Uganda.
Reducing Hazardous Alcohol Use and Optimizing Treatment as Prevention Among Men Living With HIV in Risk Environments
Khanya Ekhaya: A Home-Based Intervention
Selection of Resistant Mutations to Dolutegravir in PLWH Treated in Mozambique
Prospective Multicenter Study of the Relationship Between Virological Effectiveness and Compliance in HIV-1-infected Patients Treated With Bictegravir
Optimizing Care Delivery to Support Reengagement in PLWH Returning to HIV Care After Treatment Lapses in Zambia
Improving Treatment Adherence in HIV-Infected Individuals